Gregory Day, PhD

I maintain special clinical interest in the diagnosis and management of patients with rapidly progressive dementia (including Creutzfeldt-Jakob disease), and autoimmune-mediated encephalitis (including patients with NMDA-receptor encephalitis and similar diseases)

My research strives to integrate clinical (e.g., symptoms and signs) and paraclinical measures (e.g., structural/functional/PET neuroimaging, cerebrospinal fluid biomarkers) to inform the pathophysiology of neurodegenerative and autoimmune causes of dementia, while improving diagnostic accuracy, access to disease-modifying therapies, and patient outcomes.

Scroll to Top